Project
HealthCare
Vision
Envisioning a collaborative healthcare ecosystem where ethical use of data-driven insights and novel solutions empower professionals to transform decision-making, streamline resource utilization, and elevate patient care to its highest standard.
Mission
Our mission is to leverage data analytics and extensive research to address the healthcare challenges in Slovakia. We aim to:
- Utilize our personal skills and extensive experience for the transformation of …
read more »
Our mission is to leverage data analytics and extensive research to address the healthcare challenges in Slovakia. We aim to:
- Utilize our personal skills and extensive experience for the transformation of currently stagnating healthcare system into the thriving and prosperous field with clear long-term strategy, predictability, and continuity.
- Advance the progress of the Slovak healthcare by integrating innovative, technology-enhanced solutions that prioritize patient welfare.
- Investigate the complexities of local healthcare needs, identifying critical service gaps and opportunities for improvement within healthcare system.
- Provide specialized advisory services to a diverse group of stakeholders—including healthcare providers, policymakers, and patient groups—to facilitate well-informed and impactful decisions.
- Provide suggestions for the allocation and utility of healthcare resources improvement, ensuring greater effectiveness and best possible patient experiences.
- Advocate for the development of evidence-based healthcare policies by providing thorough analyses, strategic insights, and clear, actionable recommendations.
We are dedicated to a proactive, inclusive approach that continually seeks out novel and effective methodologies and embraces adaptive strategies to meet the dynamic demands of healthcare.
Our Values
At Project HealthCare, we embrace core values that reinforce our integrity and efficiency:
- Scientific Rigor
- Independence
- Experience
- Patient-first Approach
read more »
Scientific Rigor
We are committed to maintaining rigorous scientific methods and standards in all our work. Our dedication to thorough research and data analysis is based on established scientific techniques. This detailed approach ensures that our findings and advice are founded on solid evidence, enhancing the reliability and trustworthiness of our recommendations.
Independence
We firmly adhere to the principle of independence, both scientifically and politically. Our commitment to autonomy guarantees that our analyses and advice are uninfluenced by external factors, enabling us to provide unbiased and fair viewpoints. This independence is crucial for maintaining the integrity of and trust in our guidance.
Experience
Our extensive experience is key to our effectiveness. It is the collective expertise and skill derived from a history of successful projects that enables us to tackle complex healthcare challenges confidently, with a long-term skill set and a proven track record of successful and prompt implementations. By leveraging industry best practices and our accumulated knowledge, we provide effective solutions tailored to the unique challenges faced by our clients and their communities.
Patient-first Approach
All our efforts are aimed at the ultimate beneficiary of health services—the patient. Central to our mission is a commitment to patient-centered outcomes. We consistently give top priority to the health and satisfaction of patients, making sure they remain at the forefront of all decision-making processes. Our strategies are developed to align with patient needs, ensuring that their well-being is fundamental to our healthcare solutions.
Principal areas of interest
- Policies Related to Medicines, Medical Devices, and Medical Supplies, including HTA
- Economic Analysis of Disease Impact and the Identification of Gaps and Solutions
- Optimization and Efficiency of Healthcare Processes
- Evidence-Based Decision-Making in Healthcare
- Development of Policies and Strategies in Healthcare Sector
Our
experts
Róbert
Babeľa
is a Professor of Public Health and Vice-Chancellor responsible for research and development at the Slovak Medical University in Bratislava, Slovakia. He specializes in the field of health technology assessment and has been working in this area for second decade. …
read more »
is a Professor of Public Health and Vice-Chancellor responsible for research and development at the Slovak Medical University in Bratislava, Slovakia. He specializes in the field of health technology assessment and has been working in this area for second decade. He holds several degrees, including an MSc in International Health Technology Assessment, Pricing and Reimbursement from the University of Sheffield in Sheffield, UK. He has authored and co-authored more than 180 publications both domestically and internationally. Additionally, he has gained practical skills through his more than twenty years of experience in various roles in the healthcare sector, where he currently continues to work.
In his recent role as State Secretary at the Ministry of Health, he led the team responsible for a major drug policy change during the last decade, which was approved by the Slovak parliament and has been in effect since August 1, 2022. Currently, he prioritizes scientific projects related to the burden of chronical diseases in Slovakia, evaluates the cost-effectiveness of selected oncology screenings and cooperates with The Mental Health Leage (Liga za duševne zdravie) at the field of mental health societal burden in Slovakia.
Peter
Polák
currently serves as a strategic consultant and recognized opinion leader in the field of pharmaceutical policy, health technology assessment, and healthcare data analysis. He has extensive experience in various positions within the pharmaceutical industry.
read more »
currently serves as a strategic consultant and recognized opinion leader in the field of pharmaceutical policy, health technology assessment, and healthcare data analysis. He has extensive experience in various positions within the pharmaceutical industry.
In his recent role, he held the position of Director-General of the Pharmacy and Pharmaceutical Policy Section at the Ministry of Health and was part of the team that amended Act No. 363/2011 Coll. on the scope and conditions of reimbursement for medicinal products, medical devices, and dietetic foods in 2022. During his tenure at the Ministry of Health, he led a team responsible for reforming pharmaceutical policy, preparing a new pharmaceutical strategy for Slovakia, and implementing the new legislation. The team successfully initiated changes aimed at significantly improving the availability of innovative medicines, accelerating access, and catching up with the lag in access to innovative treatment for Slovak patients.
He obtained his education at the Faculty of Natural Sciences at Comenius University, majoring in biochemistry, and at the Slovak Academy of Sciences.Peter
Potúček
is a senior partner and acts as a strategic consultant. He specializes in the field of regulation and supervision of medicines, medical devices and clinical trials. With 20 years of extensive experience in various senior roles in the pharma and government sector, …
read more »
is a senior partner and acts as a strategic consultant. He specializes in the field of regulation and supervision of medicines, medical devices and clinical trials. With 20 years of extensive experience in various senior roles in the pharma and government sector, he has a strong background in drug development and pharma policy. He holds several degrees, including an MSc in Scientific and Regulatory assessment of new medicines from the University of Rome, Tor Vergata, Italy.
In his recent role as a Director and Secretary-General at the State Institute for Drug Control, he successfully implemented robust regulatory and legal measures, resulting in improved compliance on the Slovak market. In the role of a Management board member of European Medicines Agency, he contributed to complex EU strategy and policies on human medicines. He is passionate about advancing the public health and safety of European citizens and innovation among stakeholders in the pharma and healthcare industry. Currently he is also a member of Scientific Committee of Pharmaceutical Faculty, Comenius University in Bratislava.